HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Pre-IPO Neusoft Medical Systems - Promising Market but Full of Challenges

Pre-IPO Neusoft Xikang Holdings - The Business Model and the Concerns

Pre-IPO Gushengtang - Optimistic About Future Development

Pre-IPO Hutchmed China Ltd (13.HK) - The Strength and the Concerns

LinkDoc (零氪科技) IPO - Revised Thoughts on Valuation

Pre-IPO Brii Biosciences - Insights on Pipeline and Related Concerns

Gravity Works As WeWork Doesn't; Now Plan B

Bifurcated Chinese Express Market Developing

Equity Capital Markets

MicroTech Medical Hangzhou / Equity Capital Markets

<p>The number of diabetes cases in the world has been increasing every year, and it has been listed as the third most common disease in developed countries after cardiovascular disease and tumor. In recent years, due to the huge market potential, more and more listed companies are focusing on diabetes. For example, on May 14<sup>th</sup>, 2021, <a href="https://www.smartkarma.com/entities/microtech-medical-hangzhou-co-ltd" target="_blank" data-smartkarma-citation="entities:33367:1" rel="noopener">MicroTech Medical Hangzhou (MTM HK) </a>submitted its prospectus to HKEX and officially started the IPO process. In addition to listing on the HKEX, MicroTech also has plans to list on A-shares. So how about this Company? This insight mainly analyze the main products, the business and challenges.</p>

The number of diabetes cases in the world has been increasing every year, and it has been listed as the third most common disease in developed countries after cardiovascular disease and tumor. In recent years, due to the huge market potential, more and more listed companies are focusing on diabetes. For example, on May 14th, 2021, MicroTech Medical Hangzhou (MTM HK) submitted its prospectus to HKEX and officially started the IPO process. In addition to listing on the HKEX, MicroTech also has plans to list on A-shares. So how about this Company? This insight mainly analyze the main products, the business and challenges.

Pre-IPO MicroTech Medical (Hangzhou) - The Main Products, the Business and the Challenges